New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 6 (1) , 60-65
Abstract
Activation of methionine to S-adenosylmethionine is depressed in alcoholics. Its repletion opposes alcoholic liver cirrhosis in baboons, decreases mortality in cirrhotic patients, and opposes oxidative stress resulting from cytochrome P4502E1 (CYP2E1) induction by alcohol, ketones, and fatty acids. Their excess causes alcoholic and nonalcoholic steatohepatitis. CYP2E1 is also induced in Kupffer cells, promoting their activation and release of inflammatory cytokines, including tumor necrosis factor (TNF)-α. The TNF-α inhibitor pentoxifylline decreased mortality from alcoholic hepatitis. Polyenylphosphatidylcholine (PPC), an antioxidant phosphatidylcholine mixture extracted from soybeans, 50% of which consists of the highly bioavailable dilinoleoylphosphatidylcholine, restores phospholipids of the damaged membranes and reactivates their enzymes, including phosphatidylethanolamine methyltransferase, needed for phospholipid regeneration. In baboons, PPC prevented cirrhosis by stimulating collagenase and by opposing lipid peroxidation, which produces the fibrogenic hydroxynonenal. PPC was beneficial in patients with alcoholic hepatitis, and it opposed fibrosis in heavy drinkers and decreased aminotransferases in patients with hepatitis C. The antioxidant silymarin also successfully opposed alcoholic cirrhosis in baboons and in some but not all clinical trials; this effect also pertains to α-tocopherol. The anti-inflammatory corticosteroids and colchicine yielded mixed results. Finally, replacing long-chain with medium-chain triglycerides opposed the fatty liver experimentally and clinically.Keywords
This publication has 56 references indexed in Scilit:
- II. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver DiseaseAlcohol, Clinical and Experimental Research, 2003
- Dilinoleoylphosphatidylcholine Decreases Ethanol-Induced Cytochrome P4502E1Biochemical and Biophysical Research Communications, 2001
- Restoration of Cerebral Blood Flow Autoregulation and Reactivity to Carbon Dioxide in Acute Liver Failure by Moderate HypothermiaHepatology, 2001
- S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trialJournal of Hepatology, 1999
- Polyenylphosphatidylcholine Decreases Alcohol‐Induced Oxidative Stress in the BaboonAlcohol, Clinical and Experimental Research, 1997
- Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regressionJournal of Hepatology, 1996
- Effects of long-term vitamin E supplementation in alcoholic cirrhotics.Journal of the American College of Nutrition, 1995
- A Randomized Trial of Prednisolone in Patients with Severe Alcoholic HepatitisNew England Journal of Medicine, 1992
- Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liverJournal of Hepatology, 1989
- Colchicine in the Treatment of Cirrhosis of the LiverNew England Journal of Medicine, 1988